DM 2021-0069 |
Revised National Tuberculosis Control Program (NTP) - Health Facility Code, TB Case Number and Laboratory Specimen Number.
|
DM 2021-0052 |
Phased Implementation of Near Real Time Reporting for The National TB Control Program.
|
DM 2021-0039 |
Initial Implementation of DataToCare System.
|
DM 2021-0037 |
Provision of Honoraria to TB Medical Advisory Committee.
|
DM 2021-0036 |
Age-Specific Population Projections by Region, Province, City and Barangay to be used in the Preparation of Statistical Reports for CY 2021.
|
DM 2020-0446 |
Advisory on the Temporary Suspension for Select Regions on Securing License to Operate for COVID-19 Testing Laboratories using GeneXpert Technique.
|
DM 2020-0424 |
Interim Extension of Validity of National Tuberculosis Control Program-Directly Observed Treatment Short-Course (NTP-DOTS) Facilities' Certification.
|
DM 2020-0403 |
Monthly Reporting to the Sub-Task Group Social Recovery.
|
DM 2020-0376 |
Prioritization of COVID-19 Testing using Xpert Xpress SARS-CoV-2 Cartridges.
|
DM 2020-0375 |
Interim Guidelines on the Recording, Reporting, and Interpretation of Results from Xpert MTB/RIF Ultra (Xpert Ultra) Testing Under the National TB Control Program.
|
DM 2020-0353 |
Prioritization on the use of Delamanid 50mg.
|
DM 2020-0344 |
Template for Data Sharing Agreements (DSAs) and The Process For Its Accomplishment.
|
DM 2020-0316 |
Guidance to All COVID -19 Testing Facilities using Xpert Xpress SARS-CoV-2.
|
DM 2020-0291 |
Updated Guidelines on Handling of Specimens for Tuberculosis Testing (Xpert MTB/Rif Assay and Smear Microscopy) in the Presence of the Coronavirus Disease (COVID 19) Community Transmission.
|
DM 2020-0257 |
Reiteration of the Guidelines on Proper Management of Patients Started on Drug-Resistant TB (DR-TB) Treatment Experiencing Hepatotoxicity, Myelosuppression, Peripheral Neuropathy, and QTe Prolongation.
|
DM 2020-0226 |
Agreement during the Q 1 2020 National Consultation and Planning for the National TB Control Program held at Angeles City and Iloilo City on February 17-19 and March 9-11.
|
DM 2020-0191 |
Designation of Selected Regional TB Culture Laboratories for GeneXpert Diagnosis of Coronavirus Disease 2019 (COVID-19).
|
DM 2020-0179 |
Guidelines for Culture Laboratories on the Conduct of Mycobacteriological Tests under the Programmatic Management of Drug-resistant Tuberculosis.
|
DM 2020-0177 |
Reiteration of Policy on the Implementation of Active TB drug-safety monitoring and management (aDSM).
|
DM 2020-0147 |
Utilization of Available Allotment In Response to COVID19 Per RA 1149.
|
DM 2020-0135 |
Conduct of Assessment of Clinical Diagnosis of Tuberculosis and Support Needed from Concerned Agencies.
|
DM 2020-0129 |
Guidelines on the Use of Xpert MTB/RIF as Primary Diagnostic test for All Presumptive TB.
|
DM 2020-0128 |
Ensuring Continuous TB Services During Community Quarantine.
|
DM 2020-0083 |
Population Projection to be Used in the Preparation of Statistical Report.
|
DM 2020-0077 |
Distribution of Moxifloxacin 400mg tablet to the Programmatic Management of Drug-Resistant Tuberculosis Satellite Treatment Centers.
|
DM 2020-0074 |
Implementation of the Key Changes to the Treatment of Drug-Resistant Tuberculosis.
|
DM 2020-0016 |
Monthly Reporting of Inventory of TB Commodities through the Integrated Tuberculosis Information System of City, Provincial and Regional Warehouses, Rapid TB Diagnostics Laboratories and Health Facilities Providing TB Services.
|
DM 2020-0015 |
Cancellation of the Implementation of the Operational Research entitled "DESTroy TB: Discovering Evidence Supporting the effectiveness of the new Treatment for drug-Resistant Tuberculosis".
|
DM 2019-0450 |
Implementation of the Revised Programmatic Management of Drug-Resistant Tuberculosis (PMDT) Guidelines.
|
DM 2019-0446 |
Provision of Laptop to all Centers for Health Developments (CHDs), Provincial and (Highly Urbanized) City Health Offices for the data monitoring and validation of Integrated Tuberculosis Information System (ITIS); and to selected Directly Observed Treatment, Short-course (DOTS) facilities for encoding and reporting of Tuberculosis (TB) cases.
|
DM 2019-0442 |
Agreements during the National Consultation and Planning for National TB Control Program and National HIV/AIDS and STI Prevention and Control Program held at Davao City last September 16-20, 2019.
|
DM 2019-0419 |
Request for Submission of Requirements for the Centralized Application for Continuing Professional Development (CPD) Accreditation at the Department of Health (DOH) for CY 2020.
|
DM 2019-0387 |
Implementation of Operational Research entitled "DESTroy TB: Discovering Evidence Supporting the effectiveness of new Treatment for drug-Resistant Tuberculosis".
|
DM 2019-0353 |
Recommended Weight-based Dosing of Isoniazid for Latent TB Infection Treatment in Adults.
|
DM 2019-0342 |
Monitoring and Reporting of Department of Health (DOH) and Local Government Unit (LGU) Procured Medicines in Health Facilities.
|
DM 2019-0327 |
Guidelines on the Referral and Processing of Specimens other than Sputum for Xpert MTB/RIF Assay.
|
DM 2019-0277 |
Consolidated List of Geographically-Isolated and Disadvantaged Areas Based on the Submission of the Centers for Health Development and Ministry of Health-Bangsamoro Autonomous Region in Muslim Mindanao as of April 30, 2019
|
DM 2019-0267 |
Revised Policy on the Use of Second-line Injectable Agent in the Treatment of Drug-Resistant TB.
|
DM 2019-0257 |
Guidelines on Expanded Eligibility for Latent TB Infection (LTBI) Treatment.
|
DM 2019-0167 |
Guidelines on Proper Collection, Packaging and Transport of Sputum Specimen for TB Culture and Line Probe Assay (LPA).
|
DM 2019-0145 |
Revised Policy on the Use of Xpert MTB/RIF Test.
|
DM 2019-0097 |
Interim Guidelines on the Use of the Loop-Mediated Amplification Test for Tuberculosis (TB LAMP) as Rapid Diagnostic Tool in Selected Sites Under the National TB Control Program.
|
DM 2019-0085 |
Advisory on Prioritization of Risk Groups for Xpert MTB/RIF Testing and Approach to Presumptive Drug-resistant TB (DR-TB) during the period of Xpert MTB/RIF Cartridge Unavailability.
|
DM 2019-0077 |
Guidelines on the Distribution and Use of Point-of-Care Viral Load Tests Using Nucleic Acid Test Principle.
|
DM 2018-0376 |
Revised Implementation of Xpert Mycobacterium Tuberculosis Rifampicin (Xpert MTB/RIF) Test.
|
DM 2018-0333 |
Amendment of Population to be used in the Preparation of Statistical Reports for CY 2018 - 2022
|
DM 2018-0239 |
Provision of Free Chest X-ray Examination to Persons Deprived of Liberty.
|
DM 2018-0238 |
Reiteration of the Department Memorandum No. 2017 - 0343 dated 7 August 2017 entitled "Guidelines on the Use of Category II Treatment Regimen".
|
DM 2018-0200 |
Use of Category II Treatment Regimen for Re-treatment TB Cases among Adults and Modified Category I Treatment Regimen for New TB Cases among People Deprived of Liberty.
|
DM 2018-0173-A |
Amendment to Department Memorandum No. 2018-0173 dated 23 April 2018 entitled "Conduct of VALUE-TB Study Philippines and the Support Needed from Concerned Agencies".
|
DM 2018-0173 |
Conduct of VALUE-TB Study Philippines and the Support Needed from Concerned Agencies.
|
DM 2018-0160 |
Conduct of the Quality of TB Care Study (MEASURE TB) for the National TB Control Program and the Support Needed from Concerned Agencies.
|
DM 2018-0105 |
Provision of Certificate of Treatment Completion to Patients with Tuberculosis (TB).
|
DM 2018-0100 |
Use of Single-dose Formulation First-line Drugs from Programmatic Management of Drug-resistant TB (PMDT) Treatment Centers for Selected Drug Susceptible TB (DSTB) Patients.
|
DM 2018-0048 |
Immediate Distribution of Regional Warehouse Health Commodities for CY 2018.
|
DM 2018-0038 |
Submission of Quarterly Inventory Reports starting April 2018.
|
DM 2018-0031 |
Updated List of DOH-Designated HIV Treatment Hubs and Primary HIV Care Facilities.
|
DM 2018-0017 |
Further Clarifications and Instructions on the Compliance Procedures and Requirements of Republic Act 10173, or the "Data Privacy Act (DPA) of 2012" it's Implementing Rules and Regulations (IRR).
|
DM 2018-0011 |
Implementation of the National Online Stock Inventory and Reporting System (NOSIRS) at the Regional Level starting January 15, 2018.
|
DM 2018-0009 |
Philippine National Formulary 8th Edition Essential Medicines List 2017.
|
DM 2018-0005 |
Implementation of the Approved Medicines in the 8th Edition of the Philippine National Formulary.
|
DM 2017-0487 |
Nationwide implementation of the Provider Initiated HIV Counselling and Testing (PICT) in all DOTS Facilities.
|
DM 2017-0476 |
Guidelines to Standardize the Development of Research and Policy Briefs, Research Summaries and Infographics for Dissemination.
|
DM 2017-0475 |
Conduct of the Molecular Diagnosis of Drug Resistant Tuberculosis Study (TBRO1) for the National Tuberculosis Control Program (NTP) and the Support Needed from Concerned Agencies.
|
DM 2017-0466 |
Use of 554/100,000 Tuberculosis Incidence Rate as NTPs' Datum.
|
DM 2017-0420 |
Call for Abstracts for the 5th Global Symposium on Health Systems Research (HSR2018) and Free Health Systems Global (HSG) Membership.
|
DM 2017-0372 |
Conduct of an Assessment on the Quality of TB Diagnosis in the National Capital Region.
|
DM 2017-0362 |
Creation of the National and Regional TB Medical Advisory Committees for the Programmatic Management of Drug-Resistant TB (PMDT).
|
DM 2017-0360 |
Change in the timeline of submission for the NTP Report 2. Quarterly Report on External Quality Assurance (EQA) for TB Microscopy.
|
DM 2017-0343 |
Guidelines on the use of Category II Treatment Regimen.
|
DM 2017-0338 |
Guidance in the Observance of the National Tuberculosis Day and National Tuberculosis Awareness Month for CY 2017.
|
DM 2017-0281 |
Implementing Guidelines on Programmatic Management Drug-Resistant TB (PMDT).
|
DM 2017-0272 |
Issuance of Pharmacovigilance Monitoring System (PViMS) User Account.
|
DM 2017-0258 |
Internet Connection for National TB Control Program (NTP) Rapid Diagnostic Laboratories (RTDL), Culture Laboratories, and Drug-susceptibility Test (DST) Laboratories.
|
DM 2017-0250 |
Provision of Patient-centered Supervised Treatment for Drug-resistant Tuberculosis.
|
DM 2017-0238 |
Implementation of Standard Short Treatment Regimen (SSTR) and Use of Novel Anti-TB Drugs for Drug-resistant TB Patients.
|
DM 2017-0233 |
Guidelines on the Use of the Digital X-ray Machine provided by the Global Fund through the Philippine Business for Social Progress (PBSP) in Support of the Objective of the National TB Program (NTP) of Finding All Missing TB Cases.
|
DM 2017-0228 |
Guidelines on the Use of Pediatric Fixed Dose Combination (FDC) Anti-TB Drugs in the Treatment of TB in Children.
|
DM 2017-0176 |
Clarification on the Definition and Enhancing the Recording of "Sources of Cases" for the National TB Program Recording for Form 4. TB Treatment/IPT Card and Form 6. TB Register.
|
DM 2017-0175 |
Pilot Implementation of GX Alert System.
|
DM 2017-0174 |
Harmonization of the National Tuberculosis Control Program (NTP) Programmatic Indicators with Field Health Services Information System (FHSIS).
|
DM 2017-0152 |
Cancellation of Drug Holiday During Treatment of Drug-resistant TB.
|
DM 2017-0147 |
Guidance in the Observance of the World TB Day for CY 2017.
|
DM 2017-0137 |
Designation of Data Protection Officer or Compliance Office for Privacy.
|
DM 2017-0130 |
Feedback of the National Tuberculosis Program Year Start National Consultative Workshop held at Bali Village Hotel, Tagaytay City last February 7-9, 2017.
|
DM 2017-0075 |
World TB Day Commemoration on March 24, 2017.
|
DM 2017-0073 |
Population to Be Used in the Preparation of Statistical Reports for CY 2017-2021.
|
DM 2017-0058 |
Change of storage condition for Aminosalicylic Acid Delayed-Release Granules (PASER Granules).
|
DM 2017-0035 |
Utilization of 322/100,000 Tuberculosis (TB) Incidence Rate in the computation of the Case Detection Rate (CDR) in 2016.
|
DM 2017-0014 |
Implementing Rules and Regulations of Republic Act NO. 10767 Otherwise Known as "Comprehensive Tuberculosis Elimination Plan Act of 2016".
|
DM 2016-0423 |
Prescribed lay-out and usage of DOH and "All for Health Towards Health For All" logos on letters, formal documents, T-shirts, vest, IEC materials and other collateral materials.
|
DM 2016-0403 |
Implementation of the Approved Medicines in the 8th Edition of the Philippine National Formulary.
|
DM 2016-0395 |
Use of new Department of Health Letterhead in all Outgoing Official Correspondence of this Department.
|
DM 2016-0383 |
Use of Bedaquiline in the Treatment of Drug-resistant Tuberculosis under Program Condition.
|
DM 2016-0382 |
Province-wide Implementation of Provider Initiated HIV Counseling and Testing in Pampanga and Cavite.
|
DM 2016-0335-A |
Amendment to Department Memorandum No. 2016-0335 regarding Conduct of the Catastrophic cost study for the National TB Control Program (NTP) and the support needed from Concerned Agencies.
|
DM 2016-0335 |
Conduct of the Catastrophic Cost Study for the National TB Control Program (NTP) and the Support Needed from Concerned Agencies.
|
DM 2016-0334 |
Used of the Integrated Tuberculosis Information System (ITIS) for Submission if All NTP Quarterly Reports.
|
DM 2016-0285 |
Implementation of Xpert MTB/RIF Test as the Primary Diagnostic Tool for Presumptive Drug-Resistant Tuberculosis (DR-TB) and Presumptive Drug Susceptible Tuberculosis (DSTB) among Selected Vulnerable Populations.
|
DM 2016-0283 |
Monitoring of the Monthly Utilization and Inventory of All DOH Procured Medicines.
|
DM 2016-0276 |
Guidelines for DOH Publications.
|
DM 2016-0273 |
Observance of the August 2016 National Lung Month with theme: "END TB: SAMA-SAMANG Hanapin, Gamutin, Pagalingin LAHAT".
|
DM 2016-0221 |
Use of Revised NTP Laboratory Recording and Reporting Forms and Timeline of Submission of NTP Laboratory Quarterly Report.
|
DM 2016-0188 |
Updated List of DOH-Designated HIV Treatment Hubs and Satellite Treatment Hubs.
|
DM 2016-0133 |
Integration of Programmatic Management of Drug-resistant Tuberculosis (PMDT) Services into Basic Directly Observe Treatment Short course (DOTS) Services in Health Facilities.
|
DM 2016-0119 |
Collection of Data for Australian Tuberculosis Modeling Network (Autumn)/Optima TB by the National TB Control Program (NTP).
|
DM 2016-0059 |
Recording and Reporting of Hospital TB DOTS Indicators.
|
DM 2016-0043 |
Lifting of Department Memorandum No. 2015-0356: Temporary Change in the Standard Treatment Regimen for Drug Resistant TB Cases and Drug Stock Level to be Provided to Treatment Sites (TS) and IDOTS Facilities.
|
DM 2016-0034 |
Classification of Tuberculosis (TB) Disease Based on Bacteriological Status of Drug-Resistant Cases.
|
DM 2016-0028 |
Adjusted Tuberculosis (TB) Incidence Rate for 2016.
|
DM 2016-0026 |
Support Needed for the Conduct of the 2016 National TB Prevalence Survey (NTPS).
|
DM 2015-0356 |
Temporary Change in the Standard Treatment Regimen for Drug Resistant TB Cases and Drug Stock Level to be Provided to Treatment Sites (TS) and IDOTS Facilities.
|
DM 2015-0339 |
New Uniform for DOH Employees for CY 2016-2018.
|
DM 2015-0325 |
Updates on the Procurement of CAT II Anti-TB Medicines and Request for Procurement of Streptomycin and Ethambutol.
|
DM 2015-0321 |
Updates on the Procurement of TB Medicine in Children.
|
DM 2015-0304 |
Change of Storage Condition for Para-Aminosalicylic Acid Delayed-Release Granules (PASER Granules).
|
DM 2015-0294 |
Revised Clinical and Laboratory Baseline and Follow-up for Drug Resistant Tuberculosis (DR-TB) Patients.
|
DM 2015-0271 |
Full Implementation of Xpert MTB/RIF under the Revised NTP MOP for Case Finding of All Types of TB.
|
DM 2015-0270 |
Submission of Xpert MTB/RIF On-Site Evaluation Checklist for the 2015 Rollout and Name of Personnel to be Trained for Xpert Processing.
|
DM 2015-0260 |
Revised Diagnostic Algorithm Using Xpert MTB/RIF.
|
DM 2015-0233 |
Guide for 2015 NTP Reporting of Treatment Outcomes of 2014 Drug-Susceptible TB Patient Cohort.
|
DM 2015-0228 |
Expanded List of PMDT Ancillary Drugs.
|
DM 2015-0200 |
Implementation of Operational Research Entitled "Feasibility, Effectiveness and Safety of 9-Month Treatment Regimen for Multi Drug-resistant Tuberculosis in the Philippines".
|
DM 2015-0185 |
Submission of National Tuberculosis Control Program (NTP) Reports Using Integrated TB Information System (ITIS) for PMDT Treatment Facilities.
|
DM 2015-0176 |
Development and Use of the Integrated Tuberculosis Information System (ITIS) Laboratory Module.
|
DM 2015-0114 |
Collection of Treatment Outcome of TB Patients for the "Surveillance of Moxifloxacin and Pyrazinamide Resistance among TB Patients in the Philippines".
|
DM 2015-0110-A |
Amendment of Department Memorandum No. 2015-110 Which Provides for the Product Recall Order of Rifampicin (RIFANID) Suspension 200mg/5mL.
|
DM 2015-0110 |
Product Recall Order of Rifampicin (RIFANID) Suspension 200mg/5mL.
|
DM 2015-0100 |
Advisory on the distribution of Ziehl-Neelsen staining kits expiring in 2015.
|
DM 2015-0095 |
Adjustment of TB-HIV Cohort Reporting and Regional Coordination on HIV Testing Kits for NTP.
|
DM 2015-0094 |
Hiring of NTP Data Officers for Regional NTP.
|
DM 2015-0085 |
Initiation of P-Aminosalicylate Sodium to Newly Enrolled Drug Resistant TB (DR-TB) Cases.
|
DM 2015-0073 |
Prescribe Lay-out and Usage of DOH Logo on T-Shirts, Vest and Collaterals.
|
DM 2015-0069 |
Utilization of Adjusted TB Incidence Rate for 2015.
|
DM 2015-0065 |
Kick-Off Activity for 2015 World TB Day and Meeting/Discussion with Regional Directors, ARMM Secretary and Respective Budget Officers on the 2015 Budget of the Disease Prevention and Control Bureau (DPCB) on March 16, 2015 at DOH Central Office.
|
DM 2015-0044 |
Designation of regional point-person for TB-HIV Collaboration.
|
DM 2015-0025 |
Implementation of "Feasibility, effectiveness, and safety of 9-month treatment regimen for multidrug-resistant tuberculosis in the Philippines" operational research.
|
DM 2015-0018 |
Call For Application to the Fundamentals of Operational Research.
|
DM 2014-0302 |
Quarterly Monitoring of TB Expert Project Implementation in UNITAID Sites.
|
DM 2014-0285 |
Reiteration of the Department Order No. 2009-0116, entitled Rules and Procedures on the Preparation and Approval of Administrative Issuances in the Department of Health.
|
DM 2014-0284 |
Utilization of the Integrated TB Information System (ITIS) in Quarterly National TB Control Program (NTP) Reports.
|
DM 2014-0283 |
Reiteration on the Implementation of Xpert MTB/RIF under the Revised NTP Manual of Procedure (MOP) 5thEdition.
|
DM 2014-0280 |
Implementation of the Revised NTP Manual of Procedures (MOP) 5thEdition.
|
DM 2014-0230 |
Submission of Updated List of NTP Coordinators.
|
DM 2014-0218 |
Implementation of Xpert MTB/RIF under the Revised NTP Manual of Procedure (MOP) 5thEdition.
|
DM 2014-0163 |
Identification of Potential Treatment Facilities for the Scale-Up and Expansion of the Programmatic Management of Drug Resistant Tuberculosis.
|
DM 2014-0147 |
Amendments in the LGU Scorecard 2012-2016 Indicators.
|
DM 2014-0119 |
Assistance of Impact Project to Ensure Timely NTP Reports.
|
DM 2014-0008 |
Population to Use for CY 2011-2016.
|
DM 2011-0218 |
Provision of Anti-TB Drugs to All Forms of Tuberculosis based on WHOs Recommendation.
|
DM 2011-0074 |
Commemoration of the 2011 World TB Day on March 24, 2011 at AFP Medical Center Gym, Quezon City.
|
DM 2011-0060 |
Referral of Re-Treatment TB cases to Treatment Centers.
|
BULLETIN-7-18-2017 |
ONAR BULLETIN-7-18-2017.
|